RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 The Promising Future of Acute Lymphoblastic Leukemia Treatment
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 6
SP 30
OP 31
DO 10.1177/155989771306024
UL http://mdc.sagepub.com/content/13/6/30.abstract
AB One of the most important advances in the treatment of acute lymphoblastic leukemia (ALL) is the development of monoclonal antibody therapies. Multiple derivatives of this therapy have been developed, each with unique targets and mechanisms of action. This article discusses the monoclonal antibody-based therapies for the treatment of ALL, ALL in older adolescent and young adult patients, and minimal residual disease in ALL.